Cargando…

The association between CCR5 Δ32 polymorphism and susceptibility to breast cancer

BACKGROUND: Chemokine C-C motif receptor 5 (CCR5) gene polymorphisms have been proposed to play important roles in tumors. Δ32 polymorphism of this gene might correlate with breast cancer (BC) susceptibility. Nevertheless, inconsistent conclusions have been achieved as yet. We carried out this meta-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junlong, Peng, Yuan, Liu, Hui, Wu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669929/ https://www.ncbi.nlm.nih.gov/pubmed/29137303 http://dx.doi.org/10.18632/oncotarget.19959

Ejemplares similares

Association between the CCR5Δ32 polymorphism and preeclampsia
por: Paula Telini, Bianca de, et al.
Publicado: (2014)

The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)

The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005)

Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer’s disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer’s disease)
por: Khorram Khorshid, Hamid Reza, et al.
Publicado: (2012)

CCR2-64I and CCR5Δ32 Polymorphisms in Korean Patients with Myasthenia Gravis
por: Kim, Hyun Sook, et al.
Publicado: (2007)

The CCR5Δ32 Polymorphism in Brazilian Patients with Sickle Cell Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2014)

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
por: Tene, Oren, et al.
Publicado: (2021)

Effect of CCR5-Δ32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis
por: Liu, SiJie, et al.
Publicado: (2012)

CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019)

CCR5-Δ32 gene variant frequency in the Turkish Cypriot population
por: Fahrioglu, Umut, et al.
Publicado: (2020)

Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran
por: Heydarifard, Zahra, et al.
Publicado: (2017)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation
por: Panda, Aditya K., et al.
Publicado: (2020)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?
por: Arababadi, Mohammad K., et al.
Publicado: (2009)

COVID-19 prevalence and mortality is associated with the allele frequency of CCR5-Δ32
por: Saadat, Mostafa
Publicado: (2021)

Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
por: Li, Ting, et al.
Publicado: (2019)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia
por: Chelbi, Hanen, et al.
Publicado: (2021)

A Study on the Association between CCRΔ32 Mutation and HCV Infection in Iranian Patients
por: Bineshian, Farahnaz, et al.
Publicado: (2018)

CCR5Δ32 mutations do not determine COVID-19 disease course
por: Bernas, Stefanie N., et al.
Publicado: (2021)

CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients
por: D'Angelo, Rosalia, et al.
Publicado: (2011)

The CCR5-Delta32 Genetic Polymorphism and HIV-1 Infection Susceptibility: a Meta-analysis
por: Ni, Jun, et al.
Publicado: (2018)

The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population
por: Maestri, Alvino, et al.
Publicado: (2015)

CCR5‐Δ32 polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients
por: Molad, Jeremy, et al.
Publicado: (2022)

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
por: Jensen, Björn-Erik Ole, et al.
Publicado: (2023)

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2011)

Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?
por: Starčević Čizmarević, Nada, et al.
Publicado: (2020)

CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus
por: Ndikom, Basil Chukwuebuka, et al.
Publicado: (2022)

Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population
por: TAJBAKHSH, Amir, et al.
Publicado: (2021)

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
por: Huyveneers, Laura E. P., et al.
Publicado: (2022)

Generation of human induced pluripotent stem cells from individuals with a homozygous CCR5Δ32 mutation
por: Chen, Guibin, et al.
Publicado: (2019)

Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis
por: Lindner, Ewald, et al.
Publicado: (2007)

Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR
por: Sorokina, Alyona, et al.
Publicado: (2022)

CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population
por: Kulmann-Leal, Bruna, et al.
Publicado: (2021)

Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity—A Preliminary Report
por: Ganczak, Maria, et al.
Publicado: (2017)

Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Δ32 Deletion
por: Parczewski, Milosz, et al.
Publicado: (2011)

The global distribution of CCR5 delta 32 polymorphism: role in HIV-1 protection
por: Gupta, Anuroopa, et al.
Publicado: (2012)

Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
por: Qi, Chunxia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0a76ns9jb1l5sdup6i7lan6qj5